Bifidobacterial Interactions in Human Gut Microbiota

Bifidobacteria are among the first colonisers of the human gastrointestinal tract, particularly in breast-fed infants, and they maintain a stable albeit lower presence throughout adulthood. These Gram-positive anaerobes possess specialised metabolic capabilities that allow them to utilise host-derived and dietary glycans, including human milk oligosaccharides (HMOs) and mucin-associated carbohydrates. By fermenting these substrates, bifidobacteria produce short-chain fatty acids and aromatic lactic acids that shape the chemical landscape of the gut lumen, lower its pH and inhibit pathogens. Interactions between bifidobacterial species often involve cross-feeding, whereby one strain degrades complex glycans into simpler metabolites that support the growth of other members of the community. Such trophic networks contribute to ecological stability and resilience of the microbiota. Beyond nutrient exchange, bifidobacteria engage in molecular communication with the host, modulating epithelial barrier integrity and immune maturation through microbial metabolites and surface molecules. The balance of bifidobacterial populations has been linked to protection against allergy, inflammation and metabolic dysregulation, making them key targets for probiotic and synbiotic interventions aimed at promoting human health across the life course.

Research from Nature Portfolio

Recent studies have refined our understanding of infant bifidobacterial colonisation dynamics. High-throughput quantification of Bifidobacterium longum subsp. infantis in longitudinal cohorts revealed that this specialist HMO utiliser often establishes itself later in the breastfeeding period than previously thought, even where milk oligosaccharide profiles remain constant. This finding underscores the importance of temporal niche availability for strain-level persistence. Another investigation demonstrated that breastmilk-promoted bifidobacteria convert aromatic amino acids into aromatic lactic acids via a dedicated dehydrogenase. These metabolites engage the host’s aryl hydrocarbon receptor and hydroxycarboxylic acid receptor pathways, directly influencing mucosal immune responses and systemic cytokine profiles. Foundational genetic work has also identified an ATP-binding cassette transporter as a key determinant of fucosyllactose utilisation by infant bifidobacteria, linking specific gene clusters to shifts in community composition and metabolite outputs in early life.

Bifidobacterial Interactions in Human Gut Microbiota publication trend

The graph below shows the total number of articles in bifidobacterial interactions in human gut microbiota across all publications each year (not limited to Nature Index journals).

Technical terms

Human milk oligosaccharides (HMOs): Complex sugars present in breast milk that selectively nourish bifidobacteria.

Cross-feeding: Metabolic cooperation in which one microbe consumes the breakdown products released by another.

Synbiotic: A formulation combining live microbial strains (probiotics) with specific substrates (prebiotics) to enhance mutual survival and function.

Aromatic lactic acids: Metabolites formed when bifidobacteria ferment aromatic amino acids, with signalling roles in the host.

Aryl hydrocarbon receptor (AhR): A host transcription factor activated by microbial metabolites that regulates immune and barrier functions.

References

1. Longitudinal quantification of Bifidobacterium longum subsp. infantis reveals late colonization in the infant gut independent of maternal milk HMO composition. Nature Communications (2024).
2. Milk oligosaccharide-driven persistence of Bifidobacterium pseudocatenulatum modulates local and systemic microbial metabolites upon synbiotic treatment in conventionally colonized mice. Microbiome (2023).
3. Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Frontiers in Microbiology (2016).
4. Gut Bifidobacteria Populations in Human Health and Aging. Frontiers in Microbiology (2016).
5. Bifidobacteria-mediated immune system imprinting early in life. Cell (2021).
6. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nature Communications (2016).
7. Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut. Nature Microbiology (2021).
8. Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem. The ISME Journal: Multidisciplinary Journal of Microbial Ecology (2019).
9. Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiology (2014).
10. Bifidobacteria and Their Molecular Communication with the Immune System. Frontiers in Microbiology (2017).